Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults. In June, the ACR released an updated guideline on the management of rheumatoid arthritis.1 The guideline includes 44 recommendations—seven of which are strong and 37 conditional. It underscores the role of methotrexate as a cornerstone therapy and emphasizes minimizing glucocorticoids, when possible. It also includes new recommendations for specific high-risk groups. Learn more in our article below.
Plus, a vast repository of new research related to RA was presented to participants during ACR Convergence 2020. To help you sort through the noise, Elizabeth (Blair) Solow, MD, an assistant professor of medicine in the Division of Rheumatic Diseases at UT Southwestern Medical Center, Dallas, reviewed the abstracts and presented her picks for the top research in RA. Stay tuned for picks from ACR Convergence 2021.